Skip to main content
SpringerLink
Log in

(S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid–Nitric Oxide (GIT-27NO) – New Dress for Nitric Oxide Mission

  • Chapter
  • First Online:
Nitric Oxide (NO) and Cancer

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

  • 1035 Accesses

Abstract

Nonsteroidal-anti-inflammatory drugs modified by covalent attachment of nitric oxide (NO) have been recognized as compounds with antitumor properties. By adopting this approach the new compound GIT-27NO was synthesized at GaNiAl Immunotherapeutics Inc. (Wilmington, Delaware, USA) on the basis of the anti-inflammatory isoxazoline derivative VGX-1027. In contrast to the usual modification, i.e., connection via a spacer molecule, GIT-27NO was generated by direct addition of a releasing NO moiety. Contrary to the parental compound which is completely inefficient as an antitumor drug, the modified compound acquired strong anticancer potential. The drug reduced the growth of various cell lines in vitro as well as some solid localized and even metastatic tumors in vivo. Decreased viability of tumor cells was caused by induction of different types of programmed cell death whereas accidental cell death was a secondary event. The outcome of the drug treatment was independent of the type of intracellular response, since the absence or inactivation of key executive mediators of apoptosis, like p53 or caspases, did not affect the death signal triggered by GIT-27NO. Furthermore, cells made resistant to apoptotic stimuli are sensitive to GIT-27NO as well. Although the drug efficacy is explicitly related to NO liberation, GIT-27NO did not function as a simple exogenous donor. Signal for NO release came from cells, and further events included the generation of ROS, RNS and subsequent nitration of tyrosine residues, caspase inhibition, or decreased activity of the YY1 repressor. The drug effect on the MAP signaling pathway was heterogeneous and defined by the cell specificity, the plasticity of the agent’s action, its high efficacy, and low toxicity and suggests that GIT-27NO is a candidate for anticancer drug of the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham, M.C., and Shaham, S. (2004). Death without caspases, caspases without death. Trends Cell Biol. 14, 184–193.

    Article  PubMed  CAS  Google Scholar 

  • Adams, C., McCarthy, H.O., Coulter, J.A., Worthington, J., Murphy, C., Robson, T., and Hirst, D.G. (2009). Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. Gene Med. 2, 160–168.

    Google Scholar 

  • Arbabi, S., and Maier, R.V. (2002). Mitogen-activated protein kinases. Crit. Care Med. 30, 74–79.

    Article  Google Scholar 

  • Bak, A.W., McKnight, W., Li, P., Del Soldato, P., Calignano, A., Cirino, G., and Wallace, J.L. (1998). Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci. 62, 367–373.

    Article  Google Scholar 

  • Bilir, A., Altinoz, M.A., Erkan, M., Ozmen, V., and Aydiner, A. (2001). Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro. Pathobiology 69, 120–126.

    Article  PubMed  CAS  Google Scholar 

  • Blaise, G.A., Gauvin, D., Gangal, M., and Authier, S. (2005). Nitric oxide, cell signaling and cell death. Toxicology 208, 177–192.

    Article  PubMed  CAS  Google Scholar 

  • Bogdan, C. (2001). Nitric oxide and the regulation of gene expression. Trends Cell Biol. 11, 66–75.

    Article  PubMed  CAS  Google Scholar 

  • Bonavida, B., Khineche, S., Huerta-Yepez, S., and Garban, H. (2006). Therapeutic potential of nitric oxide in cancer. Drug Resist. Updat. 9, 157–173.

    Article  PubMed  CAS  Google Scholar 

  • Boutros, T., Chevet E., and Metrakos, P. (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol. Rev. 60(3), 261–310.

    Article  PubMed  CAS  Google Scholar 

  • Bras, M., Queenan, B., and Susin, S.A. (2005). Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc.) 70, 231–239.

    Article  CAS  Google Scholar 

  • Chan, T.A. (2002). Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol. 3, 166–174.

    Article  PubMed  CAS  Google Scholar 

  • Chan, T.A., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998). Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95, 681–686.

    Article  PubMed  CAS  Google Scholar 

  • Davis, R.J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252.

    Article  PubMed  CAS  Google Scholar 

  • de Bruin, E.C., and Medema, J.P. (2008). Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat. Rev. 34(8), 737–749.

    Article  PubMed  Google Scholar 

  • Ding, J.W., Wang, K., Brems, J.J., Gamelli, R.L. (2004). Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent. J. Am. Coll. Surg. 198(1), 67–77.

    Article  PubMed  Google Scholar 

  • Donia, M., Mijatovic, S., Maksimovic-Ivanic, D., Miljkovic, D., Mangano, K., Tumino, S., Biondi, A., Basile, F., Al-Abed ,Y., Stosic-Grujicic, S., and Nicoletti, F. (2009). The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis. Eur. J. Pharmacol. 615, 228–233.

    Google Scholar 

  • Dube, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., and Moher, D. (2007). The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann. Intern. Med. 146, 365–375.

    PubMed  Google Scholar 

  • Dunlap, T. (2008). Nitrates and NO–NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality. Nitric Oxide 19, 115–124.

    Article  PubMed  CAS  Google Scholar 

  • Fiers, W., Beyaert, R., Declercq, W., and Vandenabeele, P. (1999). More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719–7730.

    Article  PubMed  CAS  Google Scholar 

  • Fink, S.L., and Cookson, B.T. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907–1916.

    Article  PubMed  CAS  Google Scholar 

  • Fiorucci, S., Santucci, L., Antonelli, E., Distrutti, E., Del Sero, G., Morelli, O., Romani, L., Federici, B., Del Soldato, P., and Morelli, A. (2000). NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology 118, 404–421.

    Article  PubMed  CAS  Google Scholar 

  • Fu, X., Ji, R., and Dam, J. (2009). Acute, subacute toxicity and genotoxic effect of Bio-Quinone Q10 in mice and rats. Regul. Toxicol. Pharmacol. 53, 1–5.

    Google Scholar 

  • Fukumura, D., Kashiwagi, S., and Jain, R.K. (2006). The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6, 521–534.

    Article  PubMed  CAS  Google Scholar 

  • Gabriel, B., Sureau, F., Casselyn, M., Teissie, J., and Petit, P.X. (2003). Retroactivepathway involving mitochondria in electroloaded cytochrome c-induced apoptosis. Protective properties of Bcl-2 and Bcl-XL. Exp. Cell Res. 289, 195–210.

    CAS  Google Scholar 

  • Gao, J., Liu, X., and Rigas, B. (2005). Nitric oxide-donating aspirin induces apoptosisin human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. U S A 102, 17207–17212.

    Article  PubMed  CAS  Google Scholar 

  • Garba’n, H.J., and Bonavida, B. (2001). Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas Promoter: a pivotal role for nitric oxide in the upregulation of fas geneexpression in human tumor cells. J. Immunol. 167, 75–81.

    Google Scholar 

  • Gordon, S., Akopyan, G., Garban, H., and Bonavida, B. (2006). Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125–1142.

    Article  PubMed  CAS  Google Scholar 

  • Gorka, M., Daniewski, W.M., Gajkowska, B., Lusakowska, E., Godlewski, M.M., and Motyl, T. (2005). Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel. Anticancer Drugs 16, 777–788.

    Article  PubMed  CAS  Google Scholar 

  • Gozuacik, D., and Kimchi, A. (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23, 2891–2906.

    Article  PubMed  CAS  Google Scholar 

  • Grilli, M., Pizzi, M., Memo, M., and Spano, P. (1996). Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274, 1383–1385.

    Article  PubMed  CAS  Google Scholar 

  • Handy, D.E., and Loscalzo, J. (2006). Nitric oxide and posttranslational modification of the vascular proteome: S-nitrosation of reactive thiols. Arterioscler. Thromb. Vasc. Biol. 26, 1207–1214.

    Article  PubMed  CAS  Google Scholar 

  • Hasselblatt, P., Rath, M., Komnenovic, V., Zatloukal, K., and Wagner, E.F. (2007). Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 23, 104(43), 17105–17110.

    Article  Google Scholar 

  • House, A.A., Silva Oliveira, S., and Ronco, C. (2007). Anti-inflammatory drugs and the kidney. Int. J. Artif. Organs. 30, 1042–1046.

    Google Scholar 

  • Huerta-Yepez, S., Vega, M., Escoto-Chavez, S.E., Murdock, B., Sakai, T., Baritaki, S., and Bonavida, B. (2009). Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 20(1), 39–52.

    Article  PubMed  CAS  Google Scholar 

  • Huguenin, S., Vacherot, F., Fleury-Feith, J., Riffaud, J.P., Chopin, D.K., Bolla, M., and Jaurand, M.C. (2005). Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines. Cancer Lett. 218, 163–170.

    Article  PubMed  CAS  Google Scholar 

  • Iyer, A.K., Azad, N., Wang, L., and Rojanasakul, Y. (2008). Role of S-nitrosylation in apoptosis resistance and carcinogenesis. Nitric Oxide 19, 146–151.

    Article  PubMed  CAS  Google Scholar 

  • Jana N.R. (2008). NSAIDs and apoptosis. Cell Mol. Life Sci. 65(9), 1295–1301.

    Article  PubMed  CAS  Google Scholar 

  • Kanzawa, T., Germano, I.M., Komata, T., Ito, H., Kondo, Y., and Kondo, S. (2004). Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11, 448–457.

    Article  PubMed  CAS  Google Scholar 

  • Kanzawa, T., Kondo, Y., Ito, H., Kondo, S., and Germano I. (2003). Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63, 2103–2108.

    PubMed  CAS  Google Scholar 

  • Kashfi, K., and Rigas, B. (2007). The mechanism of action of nitric oxide-donating aspirin. Biochem. Biophys. Res. Commun. 358, 1096–1101.

    Article  PubMed  CAS  Google Scholar 

  • Kashfi, K., Ryan, Y., Qiao, L. L., Williams, J. L., Chen, J., Del Soldato, P., Traganos, F., and Rigas, B. (2002). Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J. Pharmacol. Exp. Ther. 303, 1273–1282.

    Article  PubMed  CAS  Google Scholar 

  • Keeble, J.E., and Moore, P.K. (2002). Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br. J. Pharmacol. 137, 295–310.

    Article  PubMed  CAS  Google Scholar 

  • Kim, R., Emi, M., Tanabe, K., Murakami, S., Uchida, Y., and Arihiro, K. (2006). Regulation and interplay of apoptotic and non-apoptotic cell death. J. Pathol. 208, 319–326.

    Article  PubMed  CAS  Google Scholar 

  • Kopp, E., and Ghosh, S. (1994). Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265, 956–959.

    Article  PubMed  CAS  Google Scholar 

  • Krysko, D.V., Vanden Berghe, T., D’Herde, K., and Vandenabeele, P. (2008). Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44, 205–221.

    Article  PubMed  CAS  Google Scholar 

  • Lage, H. (2008). An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol. Life Sci. 65, 3145–3167.

    Article  PubMed  CAS  Google Scholar 

  • Lanas, A. (2008). Role of nitric oxide in the gastrointestinal tract. Arthritis Res. Ther. 10 Suppl 2:S4.

    Article  PubMed  Google Scholar 

  • Laskin, J.D., Heck, D.E., Gardner, C.R., and Laskin, D.L. (2001). Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxid Redox Signal 3(2), 261–271.

    Article  PubMed  CAS  Google Scholar 

  • Leon, L., Jeannin, J.F., and Bettaieb, A. (2008). Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis. Nitric Oxide 19, 77–83.

    Article  PubMed  CAS  Google Scholar 

  • Levine, B., and Yuan, J.J. (2005). Autophagy in cell death: an innocent convict? Clin. Invest. 115, 2679–2688.

    Article  CAS  Google Scholar 

  • Liedtke, C., Groger, N., Manns, M.P., and Trautwein, C. (2003). The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278, 27593–27604.

    Article  PubMed  CAS  Google Scholar 

  • Lim, H.Y., Joo, H.J., Choi, J.H, Yi, J.W., Yang, M.S., Cho, D.Y., Kim, H.S., Nam, D.K., Lee, K.B., and Kim, H.C. (2000). Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res. 6, 519–525.

    PubMed  CAS  Google Scholar 

  • Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175–184.

    Article  PubMed  CAS  Google Scholar 

  • Maksimovic-Ivanic, D., Mijatovic, S., Harhaji, L., Miljkovic, D., Dabideen, D., Fan Cheng, K., Mangano, K., Malaponte, G., Al-Abed, Y., Libra, M., Garotta, G., Nicoletti, F., and Stosic-Grujicic, S. (2008). Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo. Mol. Cancer Ther. 7, 510–520.

    Article  PubMed  CAS  Google Scholar 

  • Mangano, K., Sardesai N.Y., Quattrocchi, C., Mazzon, E., Cuzzocrea, S., Bendtzen, K., Meroni, P.L., Kim J.J., and Nicoletti F. (2008a). Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats. Br. J. Pharmacol. 155, 722–730.

    Article  PubMed  CAS  Google Scholar 

  • Mangano, K., Sardesai, N., D’Alcamo, M., Libra, M., Malaguarnera, L., Donia, M., Bendtzen, K., Meroni, P., and Nicoletti, F. (2008b). In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027. Eur. J. Pharmacol. 586, 313–321.

    Article  PubMed  CAS  Google Scholar 

  • Martínez-Ruiz, A., and Lamas, S. (2004). S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc. Res. 62, 43–52.

    Article  PubMed  Google Scholar 

  • Mijatovic, S., Maksimovic-Ivanic, D., Mojic, M., Malaponte, G., Libra, M., Cardile, V., Miljkovic, D., Harhaji, L., Dabideen, D., Cheng, K.F., Bevelacqua, Y., Donia, M., Garotta, G., Al-Abed, Y., Stosic-Grujicic, S., and Nicoletti, F. (2008). Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells. Nitric Oxide 19, 177–183.

    Article  PubMed  CAS  Google Scholar 

  • Mijatovic, S., Maksimovic-Ivanic, D., Timotijevic, G., Miljkovic, D., Donia, M., Libra, M., Coco, M., McCubrey, J., Al-Abed, Y., Korac, A., Stosic-Grujicic, S., and Nicoletti, F. (2010). Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO. Free Radic. Biol. Med. [Epub ahead of print]

    Google Scholar 

  • Mijatovic, S., Maksimovic-Ivanic, D., Radovic, J., Miljkovic, Dj., Harhaji, Lj., Vuckovic, O., Stosic-Grujicic, S., Mostarica Stojkovic, M., and Trajkovic, V. (2005). Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell Mol. Life Sci. 62, 589–598.

    Article  PubMed  CAS  Google Scholar 

  • Nadkar, A., Pungaliya, C., Drake, K., Zajac, E., Singhal, S.S., and Awasthi, S. (2006). Therapeutic resistance in lung cancer. Expert Opin. Drug Metab. Toxicol. 2, 753–777.

    Article  PubMed  CAS  Google Scholar 

  • Okada, H., and Mak, T.W. (2004). Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 4, 592–603.

    Article  PubMed  CAS  Google Scholar 

  • Oliveri, M., Daga, A., Cantoni, C., Lunardi, C., Millo, R., and Puccetti, A. (2001). DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. Eur. J. Immunol. 31, 743–751.

    Article  PubMed  CAS  Google Scholar 

  • Ouyang, N., Williams, J.L., Tsioulias, G.J., Gao, J., Iatropoulos, M. J., Kopelovich, L., Kashfi, K., and Rigas, B. (2006). Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Res. 66, 4503–4511.

    Article  PubMed  CAS  Google Scholar 

  • Paglin, S., Hollister, T., Delohery, T., Hacket, N., McMahill, M., Sphicas, E., Domingo, D., and Yahalom, J. (2001). A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61, 439–444.

    PubMed  CAS  Google Scholar 

  • Puntoni, M.D. Zanardi, M.S., and Decensi, A. (2008). Inflammation and cancer prevention. Ann. Oncol. 19(Suppl7), 225–229.

    Google Scholar 

  • Rigas, B., and Kashfi, K. (2004). Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol. Med. 10, 324–330.

    Article  PubMed  CAS  Google Scholar 

  • Rigas, B., and Williams, J.L. (2008). NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action. Nitric Oxide 19, 199–204.

    Article  PubMed  CAS  Google Scholar 

  • Roninson, I.B., Broude, E.V., and Chang, B.D. (2001). If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 4, 303–313.

    Article  PubMed  CAS  Google Scholar 

  • Scartozzi, M., Galizia, E., Freddari, F., Berardi, R., Cellerino,R., and Cascinu, S. (2004). Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat. Rev. 30, 451–459.

    Article  PubMed  CAS  Google Scholar 

  • Scripture, C.D., and Figg, W.D. (2006). Drug interactions in cancer therapy. Nat. Rev. Cancer 6, 546–558.

    Article  PubMed  CAS  Google Scholar 

  • Seger, R., and Krebs, E.G. (1995). The MAPK signaling cascade. FASEB J. 9, 726–735.

    PubMed  CAS  Google Scholar 

  • Soydan, A.S., Gaffen, J.D., Weech, P.K., Tremblay, N.M., Kargman, S., O’Neill, G., Bennett, A., and Tavares, I.A. (1997). Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur. J. Cancer 33, 1508–1512.

    Article  PubMed  CAS  Google Scholar 

  • Stojanovic, I., Cuzzocrea, S., Mangano, K., Mazzon, E., Miljkovic, D., Wang, M., Donia, M., Al Abed, Y., Kim, J., Nicoletti, F., Stosic-Grujicic, S., and Claesson. M. (2007). In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin. Immunol. 123, 311–323.

    Article  PubMed  CAS  Google Scholar 

  • Stosic-Grujicic, S., Cvetkovic, I., Mangano, K., Fresta, M., Maksimovic-Ivanic, D., Harhaji, L., Popadic, D., Momcilovic, M., Miljkovic, D., Kim, J., Al-Abed, Y., and Nicoletti, F. (2007). A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice. J. Pharmacol. Exp. Ther. 320, 1038–1049.

    Article  PubMed  CAS  Google Scholar 

  • Tuteja, N., Chandra, M., Tuteja, R., and Misra, M.K.J. (2004). Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. Biomed. Biotechnol. 2004, 227–237.

    Article  Google Scholar 

  • Vega, M.I., Jazirehi, A.R., Huerta-Yepez, S., and Bonavida B. (2005). Rituximab-induced inhibition of YY1 and Bcl-xL expression in ramos non-Hodgkin’s lymphoma cell line via inhibition of NF-κB activity: role of YY1 and Bcl-xL in fas resistance and chemoresistance, respectively. J. Immunol. 175, 2174–2183.

    PubMed  CAS  Google Scholar 

  • Vogel, V.G. (2000). Breast cancer prevention: a review of current evidence. C. A. Cancer J. Clin. 50, 156–170.

    Article  CAS  Google Scholar 

  • Wallace, J.L., and Vong, L. (2008). NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr. Opin. Investig. Drugs 9(11), 1151–1156.

    PubMed  CAS  Google Scholar 

  • Wang, S., Wang, W., Wesley, R.A., and Danner, R.L. (1999). A Sp1 binding site of the tumor necrosis factor alpha promoter functions as a nitric oxide response element. J. Biol. Chem. 274, 33190–33193.

    Article  PubMed  CAS  Google Scholar 

  • Wang, W.H., Huang, J.Q., Zheng, G.F., Lam, S.K., Karlberg, J., and Wong, B.C. (2003). Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J. Natl. Cancer Inst. 95, 1784–1791.

    Article  PubMed  CAS  Google Scholar 

  • Wiseman, H., and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313, 17–29.

    PubMed  CAS  Google Scholar 

  • Yin, M.J., Yamamoto, Y., and Gaynor, R.B. (1998). The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77–80.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, L., Chang, C.J., Bacus, S.S., and Hung, M.C. (1995). Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res. 55, 3890–3896.

    PubMed  CAS  Google Scholar 

  • Zhivotovsky, B. (2004). Apoptosis, necrosis and between. Cell Cycle 3, 64–66.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Serbian Ministry of Science (Grant 143029).

Author information

Authors and Affiliations

  1. Department of Immunology, Institute for Biological Research “Sinisa Stankovic,”, Belgrade University, Belgrade, Serbia

    Sanja Mijatovic, Danijela Maksimovic-Ivanic & Stanislava Stosic-Grujicic

  2. Department of Biomedical Sciences, University of Catania, Catania, Italy

    Marco Donia

  3. GaNiAl Immunotherapeutics Inc., Wilmington, DE, USA

    Gianni Garotta

  4. Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA

    Yousef Al-Abed

  5. Department of Biomedical Sciences, University of Catania, Via Androne, 83, Catania, 95124, Italy

    Ferdinando Nicoletti

Authors
  1. Sanja Mijatovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danijela Maksimovic-Ivanic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Donia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stanislava Stosic-Grujicic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gianni Garotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yousef Al-Abed
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ferdinando Nicoletti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferdinando Nicoletti .

Editor information

Editors and Affiliations

  1. Dept. Microbiology, Immunology &, Molecular Genetics, University of California, Los Angeles, Charles E. Young Dr. E. 609, Los Angeles, 90095, California, USA

    Benjamin Bonavida

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Mijatovic, S. et al. (2010). (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid–Nitric Oxide (GIT-27NO) – New Dress for Nitric Oxide Mission. In: Bonavida, B. (eds) Nitric Oxide (NO) and Cancer. Cancer Drug Discovery and Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1432-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1432-3_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1431-6

  • Online ISBN: 978-1-4419-1432-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation